A Comparison of the Efficacy and Safety of a Half Dose of Fluticasone Propionate with Beclamethasone Dipropionate and Budesonide in Childhood Asthma

REFERENCES

• Guidelines for the Diagnosis and Management of Asthma. Expert Panel Report II. NIH Publication 97-4051, National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD 1997
   Google Scholar
• Van Essen-Zandvliet E. E., Hughes M. D., Waalkens H. J., Duiverman J. Effects of 22 Months of Treatment with Inhaled Corticosteroids and/or Beta-2 Agonists on Lung Function, Airway Responsiveness, and Symptoms in Children with Asthma. Am. Rev. Respir. Dis. 1992; 146: 547
   PubMed Web of Science ®Google Scholar
• Lipworth B. J. Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-Analysis. Arch. Intern. Med. 1999; 159: 941
   PubMed Web of Science ®Google Scholar
• Harding S. M. The Human Pharmacology of Fluticasone Propionate. Respir. Med. 1990; 84: 25
   PubMed Web of Science ®Google Scholar
• Gustafsson P., Tsanakas J., Gold M., Primhak R. Fluticasone Propionate 200 μG/Day with Inhaled Beclomethasone Dipropionate 400 μG/Day in Mild and Moderate Asthma. Arch. Dis. Child. 1993; 69: 206
   PubMed Web of Science ®Google Scholar
• Fitzgerald D., Van Asperen P., Mellis C., Honner M. Fluticasone Propionate 750 μG/Day Versus Beclomethasone Dipropionate 1500 μG/Day: Comparison of Efficacy and Adrenal Function in Paediatric Asthma. Thorax 1998; 53: 656
   PubMed Web of Science ®Google Scholar
• Barnes N. C., Marone G., Di Maria G. U., Visser S. A Comparison of Fluticasone Propionate, 1 mg Daily, with Beclomethasone Dipropionate, 2 mg Daily, in the Treatment of Severe Asthma. Eur. Respir. J. 1993; 6: 877
   PubMed Web of Science ®Google Scholar
• Bootsma G. P., Dekhuijzen P. N.R., Festen J., Mulder P. G.H. Comparison of Fluticasone Propionate and Beclomethasone Dipropionate on Direct and Indirect Measurements of Bronchial Hyperresponsiveness in Patients with Stable Asthma. Thorax 1995; 50: 1044
   PubMed Web of Science ®Google Scholar
• Raphael G. D., Lanier R. Q., Baker J., Edwards L. A Comparison of Multiple Doses of Fluticasone Propionate in Subjects with Persistent Asthma. J. Allergy Clin. Immunol. 1999; 103: 796
   PubMed Web of Science ®Google Scholar
• Langdon C. G., Capsey L. J. Fluticasone Propionate and Budesonide in Adult Asthmatics: A Comparison Using Dry-Powder Inhaler Devices. Br. J. Clin. Res. 1994; 5: 85
   Google Scholar
• Langdon C. G., Thompson J. A Multicentre Study to Compare the Efficacy and Safety of Inhaled Fluticasone Propionate and Budesonide via Metered Dose Inhalers in Adults with Mild-Moderate Asthma. Br. J. Clin. Res. 1994; 5: 73
   Google Scholar
• Ferguson A. C., Spier S., Manjra A., Versteegh G. A. Efficacy and Safety of High-Dose Inhaled Steroids in Children with Asthma: A Comparison of Fluticasone Propionate with Budesonide. J. Pediatr. 1999; 134: 422
   PubMed Web of Science ®Google Scholar
• Williams J., Richards K. A. Ease of Handling and Clinical Efficacy of Fluticasone Propionate Accuhaler/Diskus™ Inhaler Compared with the Turbohaler™ Inhaler in Paediatric Patients. Br. J. Clin. Pract. 1997; 51: 147
   PubMedGoogle Scholar
• Hoekx J. C.M., Hedlin G., Pedersen W., Sorva R. Fluticasone Propionate Compared with Budesonide: A Double-Blind Trial in Asthmatic Children Using Powder Devices at a Dosage of 400 μg. Day. Eur. Respir. J. 1996; 9: 2263
   PubMed Web of Science ®Google Scholar
• Agertoft L., Pedersen S. A Randomized, Double-Blind Dose Reduction Study to Compare the Minimal Effective Dose of Budesonide Turbohaler and Fluticasone Propionate Diskhaler. J. Allergy Clin. Immunol. 1997; 99: 773
   PubMedGoogle Scholar
• Laird N. M., Ware J. H. Random Effects Models for Longitudinal Data. Biometrika 1982; 51: 313
   Google Scholar
• Fabbri L., Burge P. S., Croonenborgh L., Warlies F. Comparison of Fluticasone Propionate with Beclomethasone Dipropionate in Moderate to Severe Asthma Treated for One Year. Thorax 1993; 48: 817
   PubMed Web of Science ®Google Scholar
• Barnes N. C., Hallett C., Harris T. A.J. Clinical Experience with Fluticasone Propionate in Asthma: A Meta-Analysis of Efficacy and Systemic Activity Compared with Budesonide and Beclomethasone Dipropionate at Half the Microgram Dose or Less. Respir. Med. 1998; 92: 95
   PubMed Web of Science ®Google Scholar
• Osmanliev D., Bowley N., Hunter D M., Pride N B. Relation Between Tracheal Size and Forced Expiratory Volume in One Second in Young Men. Am. Rev. Respir. Dis. 1982; 126: 179
   Google Scholar
• Ferguson A. C. Persisting Airway Obstruction in Asymptomatic Children with Asthma with Normal Peak Expiratory Flow Rates. J. Allergy Clin. Immunol. 1988; 82: 19
   PubMed Web of Science ®Google Scholar
• Hyland M. E., Kenyon C. A.P., Allen R. Diary Keeping in Asthma: Comparison of Written and Electronic Methods. Br. Med. J. 1993; 306: 487
   PubMed Web of Science ®Google Scholar
• Lipworth B. J., Clark D. J., McFarlane L. C. Adrenocortical Activity with Repeated Twice Daily Dosing of Fluticasone Propionate and Budesonide Given via a Large Volume Spacer to Asthmatic School Children. Thorax 1997; 52: 686
   PubMed Web of Science ®Google Scholar
• Iolo J., Doull M., Nicholas J., Holgate S. T. Growth of Prepubertal Children with Mild Asthma Treated with Inhaled Beclomethasone Dipropionate. Am. J. Respir. Crit. Care Med. 1995; 151: 1715
   Google Scholar
• Agertoft L., Pedersen S. Short-Term Knemometry and Urine Cortisol Excretion in Children Treated with Fluticasone Propionate and Budesonide: A Dose Response Study. Eur. Respir. J. 1997; 10: 1507
   PubMed Web of Science ®Google Scholar
• Nicolaizik W. H., Marchant J. L., Preece M. A., Warner J. O. Endocrine and Lung Function in Asthmatic Children on Inhaled Corticosteroids. Am. J. Respir. Crit. Care Med. 1994; 150: 624
   PubMed Web of Science ®Google Scholar
• Zimmerman B., Gold M., Wherrett D., Hanna A. K. Adrenal Suppression in Two Patients with Asthma Treated with Low Doses of the Inhaled Steroid Fluticasone Propionate. J. Allergy Clin. Immunol. 1998; 101: 425
   PubMed Web of Science ®Google Scholar
• Goldberg S., Algur N., Levi M., Brukheimer E. Adrenal Supression Among Asthmatic Children Receiving Chronic Therapy with Inhaled Corticosteroid with and Without Spacer Device. Ann. Allergy Asthma Immunol. 1996; 76: 234
   PubMed Web of Science ®Google Scholar
• Kargül B., Tanbog˘a I., Ergeneli S., Karakoç F., Dagˇli E. Inhaler Medicament Effects on Saliva and Plaque pH in Asthmatic Children. J. Clin. Pediatr. Dent. 1998; 22: 137
   PubMedGoogle Scholar
• Risteli L., Risteli J. Biochemical Markers of Bone Metabolism. Ann. Med. 1993; 25: 385
   PubMed Web of Science ®Google Scholar
• Toogood J. H., Jennings B., Hodsman A. B., Baskerville J. Effects of Dose and Dosing Schedule of Inhaled Budesonide on Bone Turnover. J. Allergy Clin. Immunol. 1991; 88: 572
   PubMedGoogle Scholar
• Pouw E. M., Prummel M. F., Oosting H., Roos C. M. Beclomethasone Inhalation Decreases Serum Osteocalcin Concentrations. Br. Med. J. 1991; 16: 627
   Google Scholar
• Teelucksingh S., Padfield P L., Tibi L., Gough K. Inhaled Corticosteroids, Bone Formation, and Osteocalcin. J. Allergy Clin. Immunol. 1991; 88: 572
   Google Scholar
• Wisniewski A. F., Lewis S. A., Green D. J., Maslanka W. Cross Sectional Investigation of the Effects of Inhaled Corticosteroids on Bone Density and Bone Metabolism in Patients with Asthma. Thorax 1997; 52: 853
   PubMed Web of Science ®Google Scholar
• Sorva R., Turpeinen M., Juntunen-Backman K., Karonen S. Effects of Inhaled Budesonide on Serum Markers of Bone Metabolism in Children with Asthma. J. Allergy Clin. Immunol. 1992; 90: 808
   PubMedGoogle Scholar
• Hanania N., Kenneth R., Chapman M. D., William C. Dose Related Decrease in Bone Density Among Asthmatic Patients Treated with Inhaled Corticosteroids. J. Allergy Clin. Immunol. 1995; 96: 571
   PubMed Web of Science ®Google Scholar
• Bootsma G. P., Dekhujzen P. N.R., Festen J., Muldre P. G.H. Fluticasone Propionate Does Not Influence Bone Metabolism in Contrast to Beclomethasone Dipropionate. Am. J. Respir. Crit. Care Med. 1996; 153: 924
   PubMed Web of Science ®Google Scholar
• Ali N. J., Capewell S., Ward M. J. Bone Turnover During High Dose Inhaled Corticosteroid Treatment. Thorax 1991; 46: 160
   PubMed Web of Science ®Google Scholar
• Hughes J. A., Conry B. G., Male S. M., Eastell R. One Year Prospective Open Study of the Effect of High Dose Inhaled Steroids, Fluticasone Propionate, and Budesonide on Bone Markers and Bone Mineral Density. Thorax 1999; 54: 223
   PubMed Web of Science ®Google Scholar